

Uro-Vaxom has the following effects: stimulates T-lymphocytes: induces the formation of endogenous interferon; increases the content of immunoglobulin A (IgA), including in the urine.
Uro-Vaxom reduces the frequency of recurrence of urinary tract infections, especially cystitis.
Combined treatment and prevention of recurrence of chronic urinary tract infection, especially cystitis, regardless of the nature of the microorganism, in combination with antibiotics or other antimicrobial agents in adults and children over 4 years old.
1 capsule contains:
active substance: lyophilized lysate of Escherichia coli bacteria - 6 mg;
Excipients: propyl gallate (anhydrous) - 0.084 mg; sodium glutamate (anhydrous) - 3.03 mg; mannitol to 60.00 mg; pregelatinized starch - 77.00 mg; magnesium stearate - 3.00 mg; mannitol - necessary amount up to 200.00 mg;
Auxiliary substances capsule shell: iron oxide red (E 172) - 0.01 mg; iron oxide yellow (E 172) - 0.21 mg; titanium dioxide (E 171) - 0.87 mg (dyes); gelatin to 50,00 mg
No customer reviews for the moment.
For therapeutic purposes, prescribe 1 caps. daily in the morning on an empty stomach as an additional drug when carrying out conventional antimicrobial therapy until symptoms disappear, but not less than 10 days. The maximum duration of treatment is 3 months.
For the prevention of recurrence of chronic urinary tract infection, 1 caps is prescribed. daily in the morning on an empty stomach for 3 months.
If it is difficult for a child to swallow a capsule, it should be opened and the contents mixed with drinking (fruit juice, milk, etc.).
The duration of treatment or the appointment of a repeated course of therapy is determined individually, based on the general condition of the patient.
Individuals may experience mild gastrointestinal disturbances (diarrhea, nausea, vomiting), skin reactions (itching, exanthema, erythema), and limited allergic skin reactions. Rarely - a small fever. In the case of more severe complications, treatment should be discontinued and consult with your doctor.
Hypersensitivity to the drug.
Interaction with other drugs has not yet been established. As a precaution, do not use the drug two weeks before and within two weeks after ingestion of live vaccines. Immunosuppressive drugs may influence the effect of the drug.
Information about cases of overdose are absent. The nature of the drug Uro-Vaxom and the results of the study of its toxicity indicate that overdose is unlikely.
Studies and clinical trials of Uro-Vaxom (Click to expand)